|
1
|
Davis CJ Jr, Mostofi FK and Sesterhenn IA:
Renal medullary carcinoma. The seventh sickle cell nephropathy. Am
J Surg Pathol. 19:1–11. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Skolarus TA, Serrano MF, Berger DA,
Bullock TL, Yan Y, Humphrey PA and Kibel AS: The distribution of
histological subtypes of renal tumors by decade of life using the
2004 WHO classification. J Urol. 179:433–444. 2008. View Article : Google Scholar
|
|
3
|
Lopez-Beltran A, Scarpelli M, Montironi R
and Kirkali Z: 2004 WHO classification of the renal tumors of the
adults. Eur Urol. 49:798–805. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schaeffer EM, Guzzo TJ, Furge KA, Netto G,
Westphal M, Dykema K, Yang X, Zhou M, Teh BT and Pavlovich CP:
Renal medullary carcinoma: Molecular, pathological and clinical
evidence for treatment with topoisomerase-inhibiting therapy. BJU
Int. 106:62–65. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hakimi AA, Koi PT, Milhoua PM, Blitman NM,
Li M, Hugec V, Dutcher JP and Ghavamian R: Renal medullary
carcinoma: The Bronx experience. Urol. 70:878–882. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sathyamoorthy K, Teo A and Atallah M:
Renal medullary carcinoma in a patient with sickle-cell disease.
Nat Clin Pract Urol. 3:279–283. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simpson L, He X, Pins M, Huang X, Campbell
SC, Yang XJ, Perlman EJ and Bergan RC: Renal medullary carcinoma
and ABL gene amplification. J Urol. 173:1883–1888. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan A, Thomas N, Costello B, Jobling L,
de Kretser D, Broadfield E and O'Shea S: Renal medullary carcinoma:
Sonographic, computed tomography, magnetic resonance and
angiographic findings. Eur J Radiol. 35:1–7. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Selby DM, Simon C, Foley JP, Thompson IM
and Baddour RT: Renal medullary carcinoma: Can early diagnosis lead
to long-term survival? J Urol. 163:12382000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Blitman NM, Berkenblit RG, Rozenblit AM
and Levin TL: Renal medullary carcinoma: CT and MRI features. AJR
Am J Roentgenol. 185:268–272. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Swartz MA, Karth J, Schneider DT,
Rodriguez R, Beckwith JB and Perlman EJ: Renal medullary carcinoma:
Clinical, pathologic, immunohistochemical, and genetic analysis
with pathogenetic implications. Urology. 60:1083–1089. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Neville A and Hatem SF: Renal medullary
carcinoma: Unsuspected diagnosis at stone protocol CT. Emerg
Radiol. 14:245–247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Steele EL and MacLennan GT: Renal
medullary carcinoma. J Urol. 174:14492005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sternberg CN, de Mulder P, Schornagel JH,
Theodore C, Fossa SD, van Oosterom AT, Witjes JA, Spina M, van
Groeningen CJ, Duclos B, et al: EORTC Genito-Urinary Cancer Group:
Seven year update of an EORTC phase III trial of high-dose
intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in
advanced urothelial tract tumours. Eur J Cancer. 42:50–54. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sternberg CN, de Mulder PH, Schornagel JH,
Théodore C, Fossa SD, van Oosterom AT, Witjes F, Spina M, van
Groeningen CJ, de Balincourt C and Collette L: European
Organization for Research and Treatment of Cancer Genitourinary
Tract Cancer Cooperative Group: Randomized phase III trial of
high-dose-intensity methotrexate, vinblastine, doxorubicin, and
cisplatin (MVAC) chemotherapy and recombinant human granulocyte
colony-stimulating factor versus classic MVAC in advanced
urothelial tract tumors: European Organization for Research and
Treatment of Cancer Protocol no. 30924. J Clin Oncol. 19:2638–2646.
2001.PubMed/NCBI
|
|
16
|
Lopez-Beltran A, Scarpelli M, Montironi R
and Kirkali Z: 2004 WHO classification of the renal tumors of the
adults. Eur Urol. 49:798–805. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Strouse JJ, Spevak M, Mack AK, Arceci RJ,
Small D and Loeb DM: Significant responses to platinum-based
chemotherapy in renal medullary carcinoma. Pediatr Blood Cancer.
44:407–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Walsh A, Kelly DR, Vaid YN, Hilliard LM
and Friedman GK: Complete response to carboplatin, gemcitabine, and
paclitaxel in a patient with advanced metastatic renal medullary
carcinoma. Pediatr Blood Cancer. 55:1217–1220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ronnen EA, Kondagunta GV and Motzer RJ:
Medullary renal cell carcinoma and response to therapy with
bortezomib. J Clin Oncol. 24:e142006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maroja Silvino MC, Venchiarutti Moniz CM,
Munhoz Piotto GH, Siqueira S, Galapo Kann A and Dzik C: Renal
medullary carcinoma response to chemotherapy: a referral center
experience in Brazil. Rare Tumors. 5:e442013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stahlschmidt J, Cullinane C, Roberts P and
Picton SV: Renal medullary carcinoma: Prolonged remission with
chemotherapy, immunohistochemical characterisation and evidence of
bcr/abl rearrangement. Med Pediatr Oncol. 33:551–557. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Walsh AM, Fiveash JB, Reddy AT and
Friedman GK: Response to radiation in renal medullary carcinoma.
Rare Tumors. 3:e322011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Amin MB, Smith SC, Agaimy A, Argani P,
Compérat EM, Delahunt B, Epstein JI, Eble JN, Grignon DJ, Hartmann
A, et al: Collecting duct carcinoma versus renal medullary
carcinoma: An appeal for nosologic and biological clarity. Am J
Surg Pathol. 38:871–874. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Q, Galli S, Srinivasan R, Linehan WM,
Tsokos M and Merino MJ: Renal medullary carcinoma: Molecular,
immunohistochemistry, and morphologic correlation. Am J Surg
Pathol. 37:368–374. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Prasad SR, Humphrey PA, Catena JR, Narra
VR, Srigley JR, Cortez AD, Dalrymple NC and Chintapalli KN: Common
and uncommon histologic subtypes of renal cell carcinoma: Imaging
spectrum with pathologic correlation. Radiographics. 26:1795–1810.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blitman NM, Berkenblit RG, Rozenblit AM
and Levin TL: Renal medullary carcinoma: CT and MRI features. AJR
Am J Roentgenol. 185:268–272. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoshimitsu K, Irie H, Tajima T, Nishie A,
Asayama Y, Hirakawa M, Nakayama T, Kakihara D and Honda H: MR
imaging of renal cell carcinoma: Its role in determining cell type.
Radiat Med. 22:371–376. 2004.PubMed/NCBI
|
|
28
|
Zhu Q, Zhu W, Wang Z and Wu J: Clinical
and CT imaging features of mucinous tubular and spindle cell
carcinoma. Chin Med J (Engl). 127:1278–1283. 2014.PubMed/NCBI
|
|
29
|
Strobel SL, Jasper WS, Gogate SA and
Sharma HM: Primary carcinoma of the renal pelvis and ureter.
Evaluation of clinical and pathologic features. Arch Pathol Lab
Med. 108:697–700. 1984.PubMed/NCBI
|
|
30
|
Farmakis SG and Siegel MJ: Rhabdoid tumor:
An aggressive renal medullary tumor of childhood. J Comput Assist
Tomogr. 39:44–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Z, Chen J, Zhou J, Liu Y, Feng Z,
Tang L and Jin Y: Clinicopathological study and diagnosis of
rhabdoid tumor of kidney combined with metanephric adenoma. Chin
Med J (Engl). 127:4290–4291. 2014.PubMed/NCBI
|
|
32
|
Ganeshan D, Iyer R, Devine C, Bhosale P
and Paulson E: Imaging of primary and secondary renal lymphoma. AJR
Am J Roentgenol. 201:712–719. 2013. View Article : Google Scholar
|
|
33
|
Navas Martínez MC, Molina Escudero R, Soto
Delgado M, Jiménez Romero ME and Jiménez Jiménez J: Bilateral
primary renal lymphoma: Case report and bibliographic. Arch Esp
Urol. 64:904–907. 2011.PubMed/NCBI
|
|
34
|
Swartz MA, Karth J, Schneider DT,
Rodriguez R, Beckwith JB and Perlman EJ: Renal medullary carcinoma:
clinical, pathologic, immunohistochemical, and genetic analysis
with pathogenetic implications. Urol. 60:1083–1089. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hindman N, Ngo L, Genega EM, Melamed J,
Wei J, Braza JM, Rofsky NM and Pedrosa I: Angiomyolipoma with
minimal fat: Can it be differentiated from clear cell renal cell
carcinoma by using standard MR techniques? Radiology. 265:468–477.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Soto Delgdo M, Pedrero Márquez G, Arroyo
Maestre JM and Beardo Villar P: Collecting duct carcinoma of the
kidney. A contribution of 4 new cases. Arch Esp Urol. 67:714–717.
2014.PubMed/NCBI
|
|
37
|
Kwon KA, Oh SY, Kim HY, Kim HS, Lee HY,
Kim TM, Lim HY, Lee NR, Lee HJ, Hong SH and Rha SY: Clinical
features and treatment of collecting duct carcinoma of the kidney
from the Korean cancer study group genitourinary and gynecology
cancer committee. Cancer Res Treat. 46:141–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
